Haemonetics Says FDA Clears Vascular Closure Device
The device uses a fully absorbable patch and lets physicians confirm bleeding has stopped without losing guidewire access, Haemonetics said.
8 Articles
8 Articles
Haemonetics announces US FDA approval of PerQseal Elite vascular closure system
Haemonetics has announced US Food and Drug Administration (FDA) approval of the PerQseal Elite vascular closure system for large-bore arterial procedures. According to the company, the approval expands Haemonetics’ portfolio of clinically-differentiated large-bore closure devices for structural heart and endovascular procedures in the USA, following its acquisition of Vivasure Medical in January 2026. The PerQseal […]
Endovascular Today
Cardiac Interventions TodayFDA Approves Haemonetics PerQseal Elite Vascular Closure System
October 20, 2026—Haemonetics Corporation announced FDA approval of the PerQseal Elite vascular closure system for large-bore arterial procedures. According to Haemonetics, the approval expands its portfolio of large-bore closure devices for structural heart and endovascular procedures in the United States after the company’s acquisition of Vivasure Medical Limited announced in January 2026. The company stated that the PerQseal Elite system provi…
Haemonetics Announces FDA Approval of PerQseal® Elite Vascular Closure System - PressReach
BOSTON, Oct. 19, 2026 /PRNewswire/ — Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced U.S. Food and Drug Administration (FDA) approval of the PerQseal® Elite vascular closure system for large-bore arterial procedures. The approval expands Haemonetics’ portfolio of clinically-differentiated large-bore closure devices for struct…
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
